FY2026 EPS Estimates for HealthEquity, Inc. (NASDAQ:HQY) Lifted by Zacks Research

HealthEquity, Inc. (NASDAQ:HQY - Free Report) - Equities researchers at Zacks Research lifted their FY2026 EPS estimates for HealthEquity in a report released on Thursday, May 16th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $2.53 per share for the year, up from their prior estimate of $2.52. The consensus estimate for HealthEquity's current full-year earnings is $2.12 per share. Zacks Research also issued estimates for HealthEquity's Q4 2026 earnings at $0.73 EPS and FY2027 earnings at $3.60 EPS.

A number of other research analysts also recently commented on HQY. Royal Bank of Canada raised their target price on shares of HealthEquity from $90.00 to $92.00 and gave the company an "outperform" rating in a research report on Wednesday, March 20th. Barrington Research reiterated an "outperform" rating and issued a $100.00 target price on shares of HealthEquity in a research note on Friday, March 22nd. KeyCorp boosted their price objective on shares of HealthEquity from $85.00 to $95.00 and gave the stock an "overweight" rating in a research note on Friday, March 22nd. BTIG Research raised their target price on shares of HealthEquity from $100.00 to $110.00 and gave the company a "buy" rating in a research note on Wednesday, March 20th. Finally, Bank of America increased their price objective on HealthEquity from $93.00 to $97.00 and gave the company a "buy" rating in a report on Wednesday, March 20th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $96.17.

HealthEquity Stock Up 1.0 %

Shares of HQY traded up $0.81 during midday trading on Friday, reaching $79.21. 391,600 shares of the stock were exchanged, compared to its average volume of 593,281. The company has a market capitalization of $6.80 billion, a P/E ratio of 123.77, a PEG ratio of 1.23 and a beta of 0.55. The company has a current ratio of 4.76, a quick ratio of 4.76 and a debt-to-equity ratio of 0.43. HealthEquity has a 52 week low of $54.09 and a 52 week high of $84.49. The company's 50 day moving average is $80.03 and its two-hundred day moving average is $75.00.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.08. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. The firm had revenue of $262.39 million during the quarter, compared to the consensus estimate of $258.56 million.

Institutional Investors Weigh In On HealthEquity

Several hedge funds have recently modified their holdings of the company. Rise Advisors LLC acquired a new position in HealthEquity in the 1st quarter worth about $28,000. Cape Investment Advisory Inc. purchased a new position in HealthEquity during the fourth quarter valued at $27,000. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of HealthEquity in the fourth quarter valued at about $29,000. YHB Investment Advisors Inc. purchased a new stake in shares of HealthEquity during the first quarter worth about $40,000. Finally, Fidelis Capital Partners LLC acquired a new position in shares of HealthEquity during the 1st quarter worth about $42,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Delano Ladd sold 2,558 shares of the business's stock in a transaction on Friday, March 1st. The shares were sold at an average price of $82.59, for a total transaction of $211,265.22. Following the completion of the transaction, the executive vice president now directly owns 47,438 shares in the company, valued at $3,917,904.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other HealthEquity news, EVP Delano Ladd sold 2,558 shares of the business's stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $82.59, for a total value of $211,265.22. Following the completion of the transaction, the executive vice president now directly owns 47,438 shares of the company's stock, valued at $3,917,904.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jon Kessler sold 33,765 shares of the company's stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the sale, the chief executive officer now owns 126,635 shares in the company, valued at approximately $10,106,739.35. The disclosure for this sale can be found here. In the last quarter, insiders have sold 68,823 shares of company stock worth $5,482,975. 2.70% of the stock is owned by company insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.